Abstract
Kawasaki disease is an acute, systemic vasculitis of childhood and confers a 25% risk of developing coronary artery aneurysms. Its etiology is unknown, but the incidence is increasing rapidly with linked gene polymorphisms having been identified. A constellation of symptoms, epidemics and seasonality all implicate an unidentified infective or environmental cause. Intravenous immunoglobulin therapy, aspirin and steroids all form the mainstay of acute treatment and reduces the incidence of coronary artery aneurysms if given before 7 days. However, in some, these lesions persist and require ongoing management during follow-up during childhood and into adult life. Evidence for further investigations in order to minimize complications is presented in order to minimize the myofibroblast proliferation and stenosis in the long term.
Original language | English |
---|---|
Pages (from-to) | 491-501 |
Number of pages | 11 |
Journal | Future Cardiology |
Volume | 13 |
Issue number | 5 |
Early online date | 22 Aug 2017 |
DOIs | |
Publication status | Published - 1 Sept 2017 |
Keywords
- Aneurysms
- coronary artery
- Kawasaki disease
- vasculitis